Landec Corporation Sets First Quarter 2022 Earnings Conference Call for September 29, 2021 at 2 p.m. PT

Rhea-AI Summary

Landec Corporation (Nasdaq: LNDC) will announce its fiscal first quarter 2022 results on September 29, 2021, after market close. The conference call will take place at 2 p.m. Pacific time, featuring CEO Dr. Albert Bolles, CFO John Morberg, and Lifecore President Jim Hall. The presentation will include a Q&A session. A replay will be available for one week until October 6, 2021. Landec operates two businesses: Lifecore Biomedical, a CDMO for sterile injectables, and Curation Foods, focusing on innovative plant-based products. More details are available on Landec’s website.

SANTA MARIA, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. and Curation Foods, Inc., will hold a conference call on Wednesday, September 29, 2021 at 2 p.m. Pacific time to discuss its results for the fiscal first quarter 2022. Financial results will be reported for the 2022 fiscal first quarter ended August 29, 2021 after market close on September 29, 2021.

Landec's President and CEO, Dr. Albert Bolles, will host the Conference Call with John Morberg, Chief Financial Officer and Jim Hall, Lifecore President. A question and answer period will follow the presentation.

Date: Wednesday, September 29, 2021
Time: 2 p.m. Pacific time (5 p.m. Eastern time)
Toll Free Participant Dial-in Number: 1-877-407-3982
U.S. and International Toll Number: 1-201-493-6780
Conference ID: 13722422
Webcast: http://ir.Landec.com/events.cfm
The webcast will be available for 30 days through October 21, 2021.

A replay of the teleconference will be available for one week until midnight Eastern Time on Wednesday, October 6, 2021.
Toll free replay dial in: 1-844-512-2921
International replay: 1-412-317-6671
Replay passcode: 13722422

About Landec Corporation

Landec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Lifecore Biomedical, Inc. and Curation Foods, Inc. Landec designs, develops, manufactures and sells products for the biopharmaceutical and food industries. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, Yucatan® and Cabo Fresh® avocado products and O Olive Oil & Vinegar® premium artisan products. For more information about the Company, visit Landec’s website at www.landec.com.

Contact Information:

Investor Relations:

Jeff Sonnek

(646) 277-1263

jeff.sonnek@icrinc.com

FAQ

What date will Landec Corporation report its fiscal first quarter 2022 results?

Landec Corporation will report its fiscal first quarter 2022 results on September 29, 2021.

What time is the conference call for Landec Corporation's Q1 2022 results?

The conference call for Landec Corporation's Q1 2022 results is scheduled for September 29, 2021, at 2 p.m. Pacific time.

Who will host Landec Corporation's conference call for its Q1 2022 results?

The conference call will be hosted by CEO Dr. Albert Bolles, CFO John Morberg, and Lifecore President Jim Hall.

How can I access the webcast of Landec Corporation's Q1 2022 results?

The webcast for Landec Corporation's Q1 2022 results can be accessed at http://ir.Landec.com/events.cfm.